Skip to main content

CJ 11974

    Drugs in R & D volume 2, pages 241–242 (1999)Cite this article

    This is a preview of subscription content, access via your institution.

    Access options

    Buy single article

    Instant access to the full article PDF.

    49,54 €

    Price includes VAT (Finland)
    Tax calculation will be finalised during checkout.

    References

    1. Obach RS, Reed AE. Cross-species correlation of in vitro intrinsic clearance and in vivo clearance for CJ-11,974: considerations of the importance of non-specific binding phenomena, interspecies differences in K(M) values, and activemetabolite formation. 6th European International Society for the Study of Xenobiotics Meeting; 1997 Jun 30-Jul 3; Gothenburg, 213

      Google Scholar 

    2. Hesketh PJ, Gralla RJ, Webb RT, et al. Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis. J Clin Oncol 1999 Jan; 17: 338–43

      PubMed  CAS  Google Scholar 

    3. Hesketh PJ. Studies on new antiemetic drugs [letter, reply]. J Clin Oncol 1999 Jun; 17: 1961–2

      Google Scholar 

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    CJ 11974. Drugs R&D 2, 241–242 (1999). https://doi.org/10.2165/00126839-199902040-00004

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.2165/00126839-199902040-00004

    Keywords

    • Clin Oncol
    • Granisetron
    • Acute Emesis
    • Diphenylmethyl
    • Delayed Emesis